Custom antibody liposome conjugation and bioconjugation services for liposomes and lipid nanoparticles (LNP) used in targeted delivery, imaging, diagnostics, cell targeting, and research applications.
Antibody liposome conjugation combines the molecular specificity of antibodies with the encapsulation, membrane, and delivery advantages of lipid-based carrier systems. By attaching antibodies to liposomes or lipid nanoparticles (LNP), the final construct can be tailored for targeted delivery, cell-surface recognition, imaging, diagnostics, and research workflows.
On this page, conjugation and bioconjugation both refer to the controlled attachment of antibodies to lipid-based systems. The optimal approach is selected based on lipid composition, available surface functionalities, antibody format, linker design, and the intended application.
We support antibody functionalization across conventional liposomes, PEGylated systems, and custom LNP platforms, with strategies designed to maintain antibody activity while aligning with delivery, imaging, or assay-specific requirements.
Antibody functionalization can improve selective cell targeting and support receptor-directed delivery concepts.
Different lipid systems offer different surface properties, loading strategies, and behavior in downstream applications.
Chemistry, linker choice, and surface presentation are selected to fit the final assay, imaging, or delivery objective.
We support multiple antibody formats for liposome conjugation and liposome bioconjugation depending on targeting needs, steric constraints, and final application requirements.
Classic phospholipid vesicle systems used for encapsulation, delivery, and targeted formulation research.
Surface-modified liposomes designed to influence circulation behavior, steric shielding, and downstream functionalization options.
Lipid systems pre-equipped with reactive groups or surface handles for antibody attachment and bioconjugation.
LNP platforms used in delivery-focused applications where antibody-mediated targeting or surface recognition is desired.
Lipid-based carriers designed around tissue, receptor, or cell-type targeting strategies.
Custom liposome or LNP systems aligned to formulation, surface chemistry, and research application requirements.
We select the optimal conjugation or bioconjugation route based on lipid composition, reactive handles, antibody format, linker needs, and the final application.
A common route for attaching antibodies or antibody fragments to lipid systems bearing maleimide-reactive groups.
Useful when carboxyl and amine functionalities are available for stable covalent attachment.
Supports selective bioconjugation strategies when controlled functionalization and cleaner reaction design are needed.
Linkers can improve spacing, accessibility, and surface presentation for antibody-functionalized liposomes or LNP systems.
Evaluation of liposome or LNP type, surface composition, and project fit.
Selection of antibody format and attachment strategy based on targeting and formulation needs.
Definition of conjugation or bioconjugation route around available reactive groups and performance goals.
Use of linkers or spacer strategies to improve accessibility and function on the lipid surface.
Support for targeting, imaging, diagnostics, and delivery-oriented project configurations.
Customized workflow aligned to the intended lipid system, antibody, and end use.
Antibody-functionalized liposomes and LNP systems can be designed for receptor-directed delivery and selective interaction with specific cell populations.
Supports imaging-active lipid systems where antibody targeting enables selective localization and tracking in research workflows.
Antibody liposome bioconjugates can be used in assay and diagnostic formats requiring selective recognition and lipid-based presentation.
Useful for evaluating lipid system behavior, optimizing targeting strategies, and developing project-specific formulations.
Explore additional antibody conjugation and bioconjugation services for related delivery, labeling, and surface-functionalization workflows.
Custom antibody conjugation for gold, magnetic, quantum dot, silica, and polymer nanoparticle systems.
Antibody-polymer conjugation for improved stability, surface engineering, and delivery-oriented applications.
View Service Details →
Biotin labeling and conjugation services for capture, detection, assay workflows, and streptavidin-based systems.
It is the attachment of antibodies or antibody fragments to liposomes or related lipid nanoparticles so the final construct can be used for targeting, delivery, imaging, diagnostics, or research applications.
They are related lipid-based systems but not always identical. This page covers both liposomes and lipid nanoparticles because antibody conjugation strategies may be adapted to either platform depending on project needs.
Whole antibodies, IgG, IgM, and antibody fragments such as Fab, F(ab')₂, and scFv may all be considered depending on the lipid platform and targeting objective.
Common routes include maleimide-thiol coupling, EDC/NHS chemistry, click chemistry, and linker-based strategies such as PEG-mediated spacing depending on the reactive groups available.
Typical applications include targeted delivery, receptor-directed studies, imaging, diagnostics, assay development, and formulation research.
Please share the lipid system type, antibody format, intended application, preferred chemistry if known, and any special formulation or stability requirements.
For the fastest review, please share your liposome or LNP type, antibody format, intended application, and any preferred conjugation or bioconjugation strategy. This helps define the most practical surface-functionalization route for your project.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.